These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 21320121)

  • 1. Coincidence of autoantibody production with the activation of natural killer T cells in α-galactosylceramide-mediated hepatic injury.
    Matsumoto H; Kawamura T; Kobayashi T; Kanda Y; Kawamura H; Abo T
    Immunology; 2011 May; 133(1):21-8. PubMed ID: 21320121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue-specific expansion of NKT and CD5+B cells at the onset of autoimmune disease in (NZBxNZW)F1 mice.
    Morshed SR; Mannoor K; Halder RC; Kawamura H; Bannai M; Sekikawa H; Watanabe H; Abo T
    Eur J Immunol; 2002 Sep; 32(9):2551-61. PubMed ID: 12207339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-appearance of autoantibody-producing B220(low) B cells with NKT cells in the course of hepatic injury.
    Fujii Y; Kawamura H; Kawamura T; Kanda Y; Matsumoto H; Kobayashi T; Yamamoto T; Aoyama T; Abo T
    Cell Immunol; 2010; 260(2):105-12. PubMed ID: 19857863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-galactosylceramide-induced liver injury in mice is mediated by TNF-alpha but independent of Kupffer cells.
    Biburger M; Tiegs G
    J Immunol; 2005 Aug; 175(3):1540-50. PubMed ID: 16034092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. alpha-galactosylceramide induces early B-cell activation through IL-4 production by NKT cells.
    Kitamura H; Ohta A; Sekimoto M; Sato M; Iwakabe K; Nakui M; Yahata T; Meng H; Koda T; Nishimura S; Kawano T; Taniguchi M; Nishimura T
    Cell Immunol; 2000 Jan; 199(1):37-42. PubMed ID: 10675273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PD-1/PDL1 and CD28/CD80 pathways modulate natural killer T cell function to inhibit hepatitis B virus replication.
    Wang XF; Lei Y; Chen M; Chen CB; Ren H; Shi TD
    J Viral Hepat; 2013 Apr; 20 Suppl 1():27-39. PubMed ID: 23458522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preactivation of NKT cells with alpha-GalCer protects against hepatic ischemia-reperfusion injury in mouse by a mechanism involving IL-13 and adenosine A2A receptor.
    Cao Z; Yuan Y; Jeyabalan G; Du Q; Tsung A; Geller DA; Billiar TR
    Am J Physiol Gastrointest Liver Physiol; 2009 Aug; 297(2):G249-58. PubMed ID: 19556359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A critical role for IFN regulatory factor 1 in NKT cell-mediated liver injury induced by alpha-galactosylceramide.
    Cao Z; Dhupar R; Cai C; Li P; Billiar TR; Geller DA
    J Immunol; 2010 Aug; 185(4):2536-43. PubMed ID: 20624945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. α-Galactosylceramide but not phenyl-glycolipids induced NKT cell anergy and IL-33-mediated myeloid-derived suppressor cell accumulation via upregulation of egr2/3.
    Huang JR; Tsai YC; Chang YJ; Wu JC; Hung JT; Lin KH; Wong CH; Yu AL
    J Immunol; 2014 Feb; 192(4):1972-81. PubMed ID: 24465013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletion of C-C Motif Chemokine Ligand 5 Worsens Invariant Natural Killer T-Cell-Mediated Hepatitis via Compensatory Up-regulation of CXCR2-Related Chemokine Activity.
    Chen L; Gu J; Qian Y; Li M; Qian Y; Xu M; Li J; Wen Y; Xia L; Li J; Xia Q; Kong X; Wu H
    Cell Mol Gastroenterol Hepatol; 2019; 7(3):623-639. PubMed ID: 30630119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tailored design of NKT-stimulatory glycolipids for polarization of immune responses.
    Hung JT; Huang JR; Yu AL
    J Biomed Sci; 2017 Mar; 24(1):22. PubMed ID: 28335781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valpha14 NKT cells activated by alpha-galactosylceramide augment lipopolysaccharide-induced nitric oxide production in mouse intra-hepatic lymphocytes.
    Ohtaki H; Ito H; Ando K; Ishikawa T; Saito K; Imawari M; Yokochi T; Moriwaki H; Seishima M
    Biochem Biophys Res Commun; 2009 Jan; 378(3):579-83. PubMed ID: 19056341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. α-Galactosylceramide-induced airway eosinophilia is mediated through the activation of NKT cells.
    Chuang YH; Wang TC; Jen HY; Yu AL; Chiang BL
    J Immunol; 2011 Apr; 186(8):4687-92. PubMed ID: 21383248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of human invariant natural killer T cells with a thioglycoside analogue of α-galactosylceramide.
    Hogan AE; O'Reilly V; Dunne MR; Dere RT; Zeng SG; O'Brien C; Amu S; Fallon PG; Exley MA; O'Farrelly C; Zhu X; Doherty DG
    Clin Immunol; 2011 Aug; 140(2):196-207. PubMed ID: 21493160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective role of interleukin-17 in murine NKT cell-driven acute experimental hepatitis.
    Wondimu Z; Santodomingo-Garzon T; Le T; Swain MG
    Am J Pathol; 2010 Nov; 177(5):2334-46. PubMed ID: 20847291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interface between innate and acquired immunity: glycolipid antigen presentation by CD1d-expressing dendritic cells to NKT cells induces the differentiation of antigen-specific cytotoxic T lymphocytes.
    Nishimura T; Kitamura H; Iwakabe K; Yahata T; Ohta A; Sato M; Takeda K; Okumura K; Van Kaer L; Kawano T; Taniguchi M; Nakui M; Sekimoto M; Koda T
    Int Immunol; 2000 Jul; 12(7):987-94. PubMed ID: 10882410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural killer T cell activation increases iNOS
    Paul S; Chhatar S; Mishra A; Lal G
    J Immunother Cancer; 2019 Aug; 7(1):208. PubMed ID: 31387637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal stem cells protect from acute liver injury by attenuating hepatotoxicity of liver natural killer T cells in an inducible nitric oxide synthase- and indoleamine 2,3-dioxygenase-dependent manner.
    Gazdic M; Simovic Markovic B; Vucicevic L; Nikolic T; Djonov V; Arsenijevic N; Trajkovic V; Lukic ML; Volarevic V
    J Tissue Eng Regen Med; 2018 Feb; 12(2):e1173-e1185. PubMed ID: 28488390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of Invariant Natural Killer T Cell Subsets in C57BL/6J Mice by Different Injection Modes of α-galactosylceramide.
    Meng M; Chen S; Gao X; Liu H; Zhao H; Zhang J; Zhang J; Chen D
    Iran J Allergy Asthma Immunol; 2020 Feb; 19(1):35-44. PubMed ID: 32245319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of hepatic NKT cells and subsequent liver injury following administration of alpha-galactosylceramide.
    Osman Y; Kawamura T; Naito T; Takeda K; Van Kaer L; Okumura K; Abo T
    Eur J Immunol; 2000 Jul; 30(7):1919-28. PubMed ID: 10940881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.